fluorodeoxyglucose f18 has been researched along with Cystadenoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ansquer, C; Frampas, E; Meurette, G; Pery, C; Regenet, N | 1 |
| Amthauer, H; Böhmig, M; Denecke, T; Felix, R; Koch, I; Langrehr, J; Lopez Hänninen, E; Plotkin, M; Ruf, J; Wiedenmann, B | 1 |
| Del Frate, C; Mortele, K; Ros, PR; Zanardi, R | 1 |
2 review(s) available for fluorodeoxyglucose f18 and Cystadenoma
| Article | Year |
|---|---|
Role and limitations of 18F-FDG positron emission tomography (PET) in the management of patients with pancreatic lesions.
Topics: Adenocarcinoma; Cystadenocarcinoma; Cystadenoma; Fluorodeoxyglucose F18; Humans; Insulinoma; Neoplasm Metastasis; Neoplasm Staging; Pancreatic Neoplasms; Pancreatitis; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed | 2010 |
Advances in imaging for pancreatic disease.
Topics: Adenocarcinoma; Adenoma, Islet Cell; Cystadenoma; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Pancreatic Cyst; Pancreatic Diseases; Pancreatic Neoplasms; Pancreatitis; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
1 other study(ies) available for fluorodeoxyglucose f18 and Cystadenoma
| Article | Year |
|---|---|
Impact of FDG-PET/MRI image fusion on the detection of pancreatic cancer.
Topics: Adenocarcinoma; Adult; Aged; Cystadenoma; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymph Nodes; Magnetic Resonance Imaging; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies | 2006 |